PMC2708991_01
The maculopapular rash on the patient's forehead.
opth-3-129f1.jpg
PMC2708991_01_opth-3-129f1.jpg
f1-opth-3-129
Twelve days after the first intravitreal injection of bevacizumab (1.25 mg), a maculopapular rash appeared on the forehead (Figure 1), as well as on both temporal regions around the eyes (Figure 2), while he didn't have this specific rash elsewhere on the body.
The maculopapular rash on the patient's temporal regions around his eyes: right (A) and left (B).
opth-3-129f2.jpg
PMC2708991_01_opth-3-129f2.jpg
f2-opth-3-129
Twelve days after the first intravitreal injection of bevacizumab (1.25 mg), a maculopapular rash appeared on the forehead (Figure 1), as well as on both temporal regions around the eyes (Figure 2), while he didn't have this specific rash elsewhere on the body.